SCHEMBL13227791

SCHEMBL13227791

COCCCSCCC(=O)OC

nearest known ligand 0.48

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 4/20 0.48
▸ ALDH1A1 P00352 3/20 0.41
▸ HSD17B10 Q99714 2/20 0.38
▸ PLA2G4B P0C869 1/20 0.37
▸ KMT2A Q03164 2/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ LMNA P02545 3/20 0.36
▸ KDM4E B2RXH2 2/20 0.36
▸ CA12 O43570 1/20 0.35
▸ CA14 Q9ULX7 1/20 0.35
▸ RECQL P46063 1/20 0.35
▸ GLS O94925 1/20 0.35
▸ TDP1 Q9NUW8 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11082919 0.92 ALDH1A1 (0.47) TSHRALDH1A1HSD17B10PLA2G4BKMT2A
SCHEMBL26777323 0.89 TSHR (0.50) TSHRALDH1A1PLA2G4BKMT2ALMNA
SCHEMBL112204 0.85 TSHR (0.63) TSHRALDH1A1HSD17B10KMT2AMEN1
SCHEMBL15282755 0.83 TSHR (0.60) TSHRALDH1A1HSD17B10KMT2AMEN1
SCHEMBL15631195 0.82 TSHR (0.50) TSHRALDH1A1HSD17B10PLA2G4BKMT2A
SCHEMBL12421758 0.82 ALDH1A1 (0.42) TSHRALDH1A1HSD17B10PLA2G4BKMT2A
SCHEMBL12417193 0.81 LMNA (0.50) TSHRALDH1A1PLA2G4BKMT2AMEN1
SCHEMBL14353413 0.81 TSHR (0.67) TSHRALDH1A1HSD17B10KMT2AMEN1
SCHEMBL23135308 0.80 ALDH1A1 (0.41) TSHRALDH1A1HSD17B10PLA2G4BKMT2A
SCHEMBL11345104 0.80 TSHR (0.48) TSHRALDH1A1HSD17B10KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8304565-B2 PEG-lipid conjugates for liposomes and drug delivery BIOZONE LABORATORIES INC. 2012-11-06 — — US disclosed
US-8304565-B2 PEG-lipid conjugates for liposomes and drug delivery BIOZONE LABORATORIES INC. 2012-11-06 — — US disclosed
US-20100210518-A1 Peg-lipid conjugates for increasing the solubility of drug compounds KELLER BRIAN CHARLES 2010-08-19 — — US disclosed
US-20100210518-A1 Peg-lipid conjugates for increasing the solubility of drug compounds KELLER BRIAN CHARLES 2010-08-19 — — US disclosed
US-20100143455-A1 Triazole antifungal agents WU NIAN 2010-06-10 — — US disclosed
US-20100143455-A1 Triazole antifungal agents WU NIAN 2010-06-10 — — US disclosed
US-20100076209-A1 PEG-lipid conjugates for liposomes and drug delivery BIOZONE LABORATORIES INC. 2010-03-25 — — US disclosed
US-20100076209-A1 PEG-lipid conjugates for liposomes and drug delivery BIOZONE LABORATORIES INC. 2010-03-25 — — US disclosed
WO-2010027496-A1 TRIAZOLE ANTIFUNGAL AGENTS WU NIAN (US) 2010-03-11 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100076209-A1 PEG-lipid conjugates for liposomes and drug delivery DAGLA, DAGLB, DGKG TSHR 2520/4885ALDH1A1 2787/4885HSD17B10 862/4885
US-20100210518-A1 Peg-lipid conjugates for increasing the solubility of drug compounds LIPA, DAGLA, MGLL TSHR 3980/4885ALDH1A1 1595/4885HSD17B10 397/4885
US-20100143455-A1 Triazole antifungal agents CYP3A7, ERG28, UGT1A7 TSHR 2904/4885ALDH1A1 3869/4885HSD17B10 3072/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback